Newspaper publication of the Audited Financial Results (Standalone & Consolidated) for fourth quarter and year ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Titan Biotech Ltd has filed with BSE the newspaper advertisements of its audited financial results (both standalone and consolidated) for the fourth quarter and full financial year ended March 31, 2026. The advertisements were published on June 1, 2026 in Financial Express (English) and Naya India (Hindi), as required under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The company has also stated that the same information is available on its website (www.titanbiotechltd.com) and on the BSE website. The BSE scrip code is 524717 and ISIN is INE150C01029.
This is a routine regulatory compliance filing and does not directly impact shareholders or the stock price. Investors should review the actual audited financial results for FY26 to assess the company's performance, as the published figures will reflect audited numbers rather than earlier estimates.